BetterLife Pharma (BETRF) EPS (Basic) (QoQ) (2011 - 2025)
Powered by 
Analysis
BetterLife Pharma (BETRF) EPS (Basic) (QoQ) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | BetterLife Pharma | 31.61 Mn | 31.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2025 | -142.18% |
| Apr 30, 2025 | 71.33% |
| Jan 31, 2025 | -203.78% |
| Oct 31, 2024 | 141.91% |
| Jul 31, 2024 | 26.78% |
| Apr 30, 2024 | -49.02% |
| Jan 31, 2024 | -429.42% |
| Oct 31, 2023 | 81.12% |
| Jul 31, 2023 | -177.97% |
| Apr 30, 2023 | 41.11% |
| Jan 31, 2023 | 87.36% |
| Oct 31, 2022 | -268.70% |
| Jul 31, 2022 | 63.00% |
| Apr 30, 2022 | 24.16% |
| Jan 31, 2022 | 36.55% |
| Oct 31, 2021 | 39.56% |
| Oct 31, 2018 | -15.27% |
| Jul 31, 2018 | 14.76% |
| Apr 30, 2018 | -402.83% |
| Jul 31, 2017 | 12.74% |